S Swaroop Vedula

Summary

Affiliation: Johns Hopkins Bloomberg School of Public Health
Country: USA

Publications

  1. pmc Network meta-analysis-highly attractive but more methodological research is needed
    Tianjing Li
    Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21212, USA
    BMC Med 9:79. 2011
  2. doi request reprint Outcome reporting in industry-sponsored trials of gabapentin for off-label use
    S Swaroop Vedula
    Center for Clinical Trials, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    N Engl J Med 361:1963-71. 2009
  3. pmc Differences in reporting of analyses in internal company documents versus published trial reports: comparisons in industry-sponsored trials in off-label uses of gabapentin
    S Swaroop Vedula
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
    PLoS Med 10:e1001378. 2013
  4. pmc Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin litigation
    S Swaroop Vedula
    Department of Epidemiology, Center for Clinical Trials, Johns Hopkins Bloomberg School of Public Health, 615 N, Wolfe Street, Mailroom W5010, Baltimore, MD 21205, USA
    Trials 13:136. 2012

Collaborators

  • Kay Dickersin
  • Lisa Bero
  • Roberta W Scherer
  • Tianjing Li
  • Edward Mills
  • Kristian Thorlund
  • Milo A Puhan
  • Steven N Goodman
  • Gerben Ter Riet
  • Sonal Singh
  • David Musch
  • Karen Robinson
  • Chris Cameron
  • Christopher Schmid
  • Thomas Trikalinos
  • Fujian Song

Detail Information

Publications4

  1. pmc Network meta-analysis-highly attractive but more methodological research is needed
    Tianjing Li
    Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21212, USA
    BMC Med 9:79. 2011
    ..Since this commentary reflects the discussion at that meeting, it is not intended to provide an overview of the field...
  2. doi request reprint Outcome reporting in industry-sponsored trials of gabapentin for off-label use
    S Swaroop Vedula
    Center for Clinical Trials, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    N Engl J Med 361:1963-71. 2009
    ..There is good evidence of selective outcome reporting in published reports of randomized trials...
  3. pmc Differences in reporting of analyses in internal company documents versus published trial reports: comparisons in industry-sponsored trials in off-label uses of gabapentin
    S Swaroop Vedula
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
    PLoS Med 10:e1001378. 2013
    ..e., what was planned and what was done). Trials were for off-label uses of gabapentin sponsored by Pfizer and Parke-Davis, and documents were obtained through litigation...
  4. pmc Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin litigation
    S Swaroop Vedula
    Department of Epidemiology, Center for Clinical Trials, Johns Hopkins Bloomberg School of Public Health, 615 N, Wolfe Street, Mailroom W5010, Baltimore, MD 21205, USA
    Trials 13:136. 2012
    ..migraine prophylaxis, treatment of bipolar disorders, neuropathic pain, and nociceptive pain...